Condition
Glioma (Any Grade) in the Brain
Total Trials
5
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 2 (1)
Trial Status
Unknown1
Not Yet Recruiting1
Enrolling By Invitation1
Active Not Recruiting1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07475390Not ApplicableActive Not RecruitingPrimary
99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging
NCT07050836Early Phase 1RecruitingPrimary
Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation
NCT07106008Not Yet RecruitingPrimary
Radiolabeled TSPO Targeted Molecular Probe in Glioma
NCT06999148Phase 2Enrolling By InvitationPrimary
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
NCT06743100UnknownPrimary
18F-Floretyrosine Expanded Access Program
Showing all 5 trials